Lipocine Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LPCN research report →
About the company
Lipocine Inc. is a biopharmaceutical firm currently in the clinical development phase, concentrating its efforts on creating medicinal products to address a range of neuroendocrine and metabolic conditions. A core aspect of the company's research and development involves formulating oral delivery methods for pharmaceutical compounds that typically suffer from low bioavailability.
- CEO
- Mahesh V. Patel
- IPO
- 2013
- Employees
- 16
- HQ
- Salt Lake City, UT, US
Price Chart
- Market Cap
- $13.87M
- P/E
- -1.22
- P/S
- 6.93
- P/B
- 0.71
- EV/EBITDA
- -0.78
- Div Yield
- 0.00%
- Gross Margin
- -8.21%
- Op Margin
- -605.86%
- Net Margin
- -571.10%
- ROE
- -66.69%
- ROIC
- -53.13%
- Revenue
- $1.98M · -82.35%
- Net Income
- $-9,627,505 · -115371.85%
- EPS
- $-1.77 · -110725.00%
- Op Income
- $-10,371,379
- FCF YoY
- -644.34%
- 52W High
- $12.37
- 52W Low
- $1.81
- 50D MA
- $2.30
- 200D MA
- $4.66
- Beta
- 0.46
- Avg Volume
- 279.80K
Get TickerSpark's AI analysis on LPCN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | Patel Mahesh V. | other | 52,781 |
| Jun 3, 26 | Higuchi John W. | other | 1,764 |
| Jun 3, 26 | Jene Jill M. | other | 1,764 |
| Jun 3, 26 | Ono Richard Dana | other | 1,764 |
| Apr 7, 26 | Higuchi John W. | buy | 40,000 |
| Apr 6, 26 | Higuchi John W. | buy | 123,000 |
| Apr 6, 26 | Patel Mahesh V. | buy | 25,000 |
| Apr 2, 26 | Patel Mahesh V. | buy | 25,000 |
| Jan 2, 26 | Patel Mahesh V. | other | 25,000 |
| Dec 18, 25 | Patel Mahesh V. | other | 8,629 |
Our LPCN coverage
Recent articles, reports, and earnings notes.
No research on LPCN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LPCN report →Similar companies
Peers in the same neighborhood.